Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-014142

Chief Technology Officer sold 7,000 shares at an average $27.61 ($193,303)

  • Chief Technology Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myer Vickesh Chief Technology Officer 2018-12-17 Option exercise +3,000 $0.65 $1,950 3,000 D
Myer Vickesh Chief Technology Officer 2018-12-17 Sale −2,300 $27.75 $63,825 700 D
Myer Vickesh Chief Technology Officer 2018-12-17 Sale −700 $28.34 $19,838 0 D
Myer Vickesh Chief Technology Officer 2018-12-18 Option exercise +4,000 $11.21 $44,840 4,000 D
Myer Vickesh Chief Technology Officer 2018-12-18 Sale −4,000 $27.41 $109,640 0 D
Derivatives
Myer Vickesh Chief Technology Officer 2018-12-17 Option exercise · Stock Option (right to buy) −3,000 82,307 D
Myer Vickesh Chief Technology Officer 2018-12-18 Option exercise · Stock Option (right to buy) −4,000 56,897 D
Open-market sales · 7,000 sh · avg $27.61 · $193,303
Loading xslF345X03/edgar.xml…